Global Parkinson's Disease Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Oct-2018
No. of pages: 130

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.

Scope of the Report:

This report studies the Parkinson's Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parkinson's Disease Treatment market by product type and applications/end industries.

There is no cure for Parkinson's disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonistsbeing used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms.

The global Parkinson's Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parkinson's Disease Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- GSK

- Merck

- Novartis

- Teva

- Boehringer Ingelheim

- Impax

- Abbvie

- Bausch Health

- Lundbeck

- Sun Pharmaceutical Industries

- Wockhardt

- Acadia Pharmaceuticals

- UCB

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Levodopa/carbidopa

- Dopamine Receptor Agonists

- MAO-Inhibitors

- COMT-inhibitors

- Anticholinergics

Market Segment by Applications, can be divided into

- Hospitals

- Clinics

Global Parkinson's Disease Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents
1 Parkinson's Disease Treatment Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Treatment
1.2 Classification of Parkinson's Disease Treatment by Types
1.2.1 Global Parkinson's Disease Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Parkinson's Disease Treatment Revenue Market Share by Types in 2017
1.2.3 Levodopa/carbidopa
1.2.4 Dopamine Receptor Agonists
1.2.5 MAO-Inhibitors
1.2.6 COMT-inhibitors
1.2.7 Anticholinergics
1.3 Global Parkinson's Disease Treatment Market by Application
1.3.1 Global Parkinson's Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Parkinson's Disease Treatment Market by Regions
1.4.1 Global Parkinson's Disease Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson's Disease Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Parkinson's Disease Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Parkinson's Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Parkinson's Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Parkinson's Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva
2.4.1 Business Overview
2.4.2 Parkinson's Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Parkinson's Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Impax
2.6.1 Business Overview
2.6.2 Parkinson's Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Impax Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbvie
2.7.1 Business Overview
2.7.2 Parkinson's Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbvie Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bausch Health
2.8.1 Business Overview
2.8.2 Parkinson's Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bausch Health Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lundbeck
2.9.1 Business Overview
2.9.2 Parkinson's Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lundbeck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharmaceutical Industries
2.10.1 Business Overview
2.10.2 Parkinson's Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharmaceutical Industries Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Wockhardt
2.11.1 Business Overview
2.11.2 Parkinson's Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Wockhardt Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Acadia Pharmaceuticals
2.12.1 Business Overview
2.12.2 Parkinson's Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Acadia Pharmaceuticals Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 UCB
2.13.1 Business Overview
2.13.2 Parkinson's Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 UCB Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Parkinson's Disease Treatment Market Competition, by Players
3.1 Global Parkinson's Disease Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson's Disease Treatment Players Market Share
3.2.2 Top 10 Parkinson's Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Parkinson's Disease Treatment Market Size by Regions
4.1 Global Parkinson's Disease Treatment Revenue and Market Share by Regions
4.2 North America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
5 North America Parkinson's Disease Treatment Revenue by Countries
5.1 North America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
5.2 USA Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6 Europe Parkinson's Disease Treatment Revenue by Countries
6.1 Europe Parkinson's Disease Treatment Revenue by Countries (2013-2018)
6.2 Germany Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.4 France Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Parkinson's Disease Treatment Revenue by Countries
7.1 Asia-Pacific Parkinson's Disease Treatment Revenue by Countries (2013-2018)
7.2 China Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.5 India Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
8 South America Parkinson's Disease Treatment Revenue by Countries
8.1 South America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
8.2 Brazil Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Parkinson's Disease Treatment by Countries
9.1 Middle East and Africa Parkinson's Disease Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
10 Global Parkinson's Disease Treatment Market Segment by Type
10.1 Global Parkinson's Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Parkinson's Disease Treatment Market Forecast by Type (2018-2023)
10.3 Levodopa/carbidopa Revenue Growth Rate (2013-2023)
10.4 Dopamine Receptor Agonists Revenue Growth Rate (2013-2023)
10.5 MAO-Inhibitors Revenue Growth Rate (2013-2023)
10.6 COMT-inhibitors Revenue Growth Rate (2013-2023)
10.7 Anticholinergics Revenue Growth Rate (2013-2023)
11 Global Parkinson's Disease Treatment Market Segment by Application
11.1 Global Parkinson's Disease Treatment Revenue Market Share by Application (2013-2018)
11.2 Parkinson's Disease Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
12 Global Parkinson's Disease Treatment Market Size Forecast (2018-2023)
12.1 Global Parkinson's Disease Treatment Market Size Forecast (2018-2023)
12.2 Global Parkinson's Disease Treatment Market Forecast by Regions (2018-2023)
12.3 North America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.6 South America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Parkinson's Disease Treatment Picture
Table Product Specifications of Parkinson's Disease Treatment
Table Global Parkinson's Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Parkinson's Disease Treatment Revenue Market Share by Types in 2017
Figure Levodopa/carbidopa Picture
Figure Dopamine Receptor Agonists Picture
Figure MAO-Inhibitors Picture
Figure COMT-inhibitors Picture
Figure Anticholinergics Picture
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Application (2013-2023)
Figure Parkinson's Disease Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Table Global Market Parkinson's Disease Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Parkinson's Disease Treatment Type and Applications
Table GSK Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Parkinson's Disease Treatment Type and Applications
Table Merck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Parkinson's Disease Treatment Type and Applications
Table Novartis Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Parkinson's Disease Treatment Type and Applications
Table Teva Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Parkinson's Disease Treatment Type and Applications
Table Boehringer Ingelheim Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Impax Basic Information, Manufacturing Base and Competitors
Table Impax Parkinson's Disease Treatment Type and Applications
Table Impax Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Parkinson's Disease Treatment Type and Applications
Table Abbvie Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bausch Health Basic Information, Manufacturing Base and Competitors
Table Bausch Health Parkinson's Disease Treatment Type and Applications
Table Bausch Health Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Lundbeck Basic Information, Manufacturing Base and Competitors
Table Lundbeck Parkinson's Disease Treatment Type and Applications
Table Lundbeck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Industries Parkinson's Disease Treatment Type and Applications
Table Sun Pharmaceutical Industries Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Parkinson's Disease Treatment Type and Applications
Table Wockhardt Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Acadia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Acadia Pharmaceuticals Parkinson's Disease Treatment Type and Applications
Table Acadia Pharmaceuticals Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Parkinson's Disease Treatment Type and Applications
Table UCB Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Players (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Players in 2016
Figure Global Parkinson's Disease Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Parkinson's Disease Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Parkinson's Disease Treatment Revenue Market Share in 2017
Figure Global Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Market Share by Regions in 2017
Figure North America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure South America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table North America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
Table North America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure USA Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Europe Parkinson's Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure Germany Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure UK Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure France Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure China Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure India Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table South America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
Table South America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure Brazil Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Type (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Type (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Type in 2017
Table Global Parkinson's Disease Treatment Revenue Forecast by Type (2018-2023)
Figure Global Parkinson's Disease Treatment Market Share Forecast by Type (2018-2023)
Figure Global Levodopa/carbidopa Revenue Growth Rate (2013-2018)
Figure Global Dopamine Receptor Agonists Revenue Growth Rate (2013-2018)
Figure Global MAO-Inhibitors Revenue Growth Rate (2013-2018)
Figure Global COMT-inhibitors Revenue Growth Rate (2013-2018)
Figure Global Anticholinergics Revenue Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatment Revenue by Application (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Application (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Application (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Application in 2017
Table Global Parkinson's Disease Treatment Revenue Forecast by Application (2018-2023)
Figure Global Parkinson's Disease Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Parkinson's Disease Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Parkinson's Disease Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure Europe Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure South America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
  • 2018-2023 Global Stroke Management Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Stroke Management market for 2018-2023. Stroke is the condition that occurs when the clot is formed in the artery and the oxygen supply to the brain is cut off, brain cells get deprived of oxygen and starts to die. Stroke can be thrombotic or embolic. Thrombotic stroke occurs when a blood clot is formed in the arteries that supply blood to the brain. This r......
  • Global C-Reactive Protein Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 137
    C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there is inflammation in the body. Scope of the Report: This report studies the C-Reactive Protein Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and sp......
  • 2018-2023 Global Structural Heart Devices Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 134
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Structural Heart Devices market for 2018-2023. A structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. Most of the structural heart conditions are present since birth (congenital), but these can also be acquired later in life, owing to wear & tear from infection. This report analzyed the treatment......
  • Global Cryoablation Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 136
    Cryoablation is a procedure of destroying tissues and cells by freezing, thereby causing cellular damage, death, and necrosis of tissues. Scope of the Report: This report focuses on the Cryoablation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The devices used for cyroablation are known as ......
  • Global Cryosurgery Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 130
    Cryosurgery is a medical procedure carried out using extremely cold temperature. It is a part of cryotherapy that is used to destroy or remove diseased tissues. Scope of the Report: This report focuses on the Cryosurgery Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Cryosurgery, being a mini......
  • Global Custom 3D Printed Implants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 134
    In 3D printing, a layer-by-layer addition method is used to produce physical objects from a 3D digital file. This technology is expected to meet the growing demands of advanced medical care by providing modified medical devices. Scope of the Report: This report focuses on the Custom 3D Printed Implants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufactur......
  • Global Custom Assays Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 135
    Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes. Scope of the Report: This report studies the Custom Assays market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Custom Assays market by product type and applicat......
  • 2018-2023 Global Transcatheter Aortic Valve Implantation (TAVI) Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 133
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Transcatheter Aortic Valve Implantation (TAVI) market for 2018-2023. Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normall......
  • 2018-2023 Global Transcatheter Mitral Valve Repair & Replacement Market Report (Status and Outlook)
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 119
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Transcatheter Mitral Valve Repair & Replacement market for 2018-2023. Cardiology has shifted focus toward transcatheter mitral valve repair and it will become the next major trend. Mitral valve anatomy is much more complex than the aortic valve, which is why it has taken more time to develop a transcatheter valve and deployment system. Over ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs